Last reviewed · How we verify
NCT02334670: CRICS
Vietnam Cryptococcal Retention in Care Study Version 1.0
trial testing Fluconazole in Meningitis, Cryptococcal in 2,612 participants. Status unknown.
31 March 2018
Quick facts
| Lead sponsor | National Hospital for Tropical Diseases, Hanoi, Vietnam |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 2,612 |
| Start date | 14 August 2015 |
| Primary completion | 31 March 2018 |
| Estimated completion | 31 March 2018 |
| Sites | 1 location across Vietnam |
Drugs / interventions tested
- Fluconazole (fluconazole) — full drug profile →
Conditions studied
- Meningitis, Cryptococcal — all drugs for Meningitis, Cryptococcal →
- Central Nervous System Fungal Infections — all drugs for Central Nervous System Fungal Infections →
- Central Nervous System Infections — all drugs for Central Nervous System Infections →
- Meningitis, Fungal — all drugs for Meningitis, Fungal →
Sponsor
National Hospital for Tropical Diseases, Hanoi, Vietnam
Who can join
18 and older, any sex, with Meningitis, Cryptococcal or Central Nervous System Fungal Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is hypothesized that implementing plasma CrAg screening in clinics providing routine HIV care will enable identification of Vietnamese adult patients with advanced HIV (CD4 ≤100 cells/μL) who have early cryptococcal disease, enable prompt preemptive treatment with high-dose fluconazole, and improve survival.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02334670
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fluconazole
Trials testing the same drug.
- NCT07395024 — A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults · Phase 1 · recruiting
- NCT06922344 — Comparison of Efficacy of Oral Fluconazole Versus Oral Itraconazole in the Treatment of Pityriasis Versicolor · Phase 4 · recruiting
- NCT05421858 — A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invas · Phase 3 · recruiting
- NCT06345794 — A Study to Assess LY4100511 (DC-853) in Healthy Adult Participants · Phase 1 · completed
- NCT06822166 — Drug Interactions Trial of Methoxyethyl Etomidate Hydrochloride · Phase 1 · completed
Other National Hospital for Tropical Diseases, Hanoi, Vietnam trials
Trials by the same sponsor.
- NCT03267407 — Vietnam Cryptococcal Retention in Care Study - Version 2.1 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02334670 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Hospital for Tropical Diseases, Hanoi, Vietnam
- Last refreshed: 13 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02334670.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing